TGTX
TG Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$27.96
+1.02 ▲ +3.79%
🌙 3월 13일 6:14 PM ET (한국 3/14 07:14)
$27.85
-0.11 ▼ -0.39%
| Index | RUT | P/E | 10.07 | EPS (ttm) | 2.78 | Insider Own | 7.27% | Shs Outstand | 0.16B | Perf Week | -4.48% |
| Market Cap | 4.46B | Forward P/E | 12.21 | EPS next Y | 65.05% | Insider Trans | -0.04% | Shs Float | 0.15B | Perf Month | -2.98% |
| Enterprise Value | 4.58B | PEG | 13.27 | EPS next Q | 0.28 | Inst Own | 65.15% | Short Float | 18.59% | Perf Quarter | -8.63% |
| Income | 0.45B | P/S | 7.24 | EPS this Y | -49.91% | Inst Trans | 2.67% | Short Ratio | 14.62 | Perf Half Y | -13.86% |
| Sales | 0.62B | P/B | 6.7 | EPS next 5Y | 0.92% | ROA | 54.5% | Short Interest | 27.52M | Perf YTD | -6.21% |
| Book/sh | 4.17 | P/C | 31.45 | EPS past 3/5Y | - | ROE | 102.75% | 52W High | -39.85% ($46.48) | Perf Year | -24.55% |
| Cash/sh | 0.89 | P/FCF | - | Sales past 3/5Y | 504.86% 426.73% | ROIC | 49.65% | 52W Low | 10.6% ($25.28) | Perf 3Y | 85.66% |
| Dividend Est. | - | EV/EBITDA | 37.04 | EPS Y/Y TTM | 1802.16% | Gross Margin | 83.62% | Volatility(W/M) | 3.76% 4.04% | Perf 5Y | -43.89% |
| Dividend TTM | - | EV/Sales | 7.43 | Sales Y/Y TTM | 87.32% | Oper. Margin | 20.01% | ATR (14) | 1.21 | Perf 10Y | 224.36% |
| Dividend Ex-Date | - | Quick Ratio | 3.29 | EPS Q/Q | -0.69% | Profit Margin | 72.56% | RSI (14) | 42.07 | Recom | 1.62 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.1 | Sales Q/Q | 78% | SMA20 | -4.36% ($29.23) | Beta | 1.88 | Target Price | $44.43 |
| Payout | - | Debt/Eq | 0.39 | Earnings | 2000000 | SMA50 | -5.28% ($29.52) | Rel Volume | 1.01 | Prev Close | $26.94 |
| Employees | 399 | LT Debt/Eq | 0.39 | EPS/Sales Surpr. | -60.28% 0.41% | SMA200 | -13.88% ($32.47) | Avg Volume(3M) | 1.88M | Price | $27.96 |
| IPO | 1995/12/14 | Option/Short | Yes/Yes | Trades | 16285 | Volume | 1,892,087 | Change | 3.79% |
뉴스 로딩 중...